Company patents
CARDIOVALVE LTD.
CARDIOVALVE LTD. exhibits a highly concentrated patent strategy, with 97.1% of its portfolio in Implants & Prosthetics, which saw a significant 50.0% decline in patenting in 2025 and a further 84.6% decline so far in 2026. While Medical Diagnostics & Surgery patents experienced a 40.0% growth in 2024, this category also saw a sharp 71.4% drop in 2025 and a complete cessation so far in 2026, indicating a potential shift away from these areas despite their initial growth.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
68 US filings (since 2023) · 7 categories · 3 themes
Implantable devices designed to repair, replace, or assist the function of blood vessels or heart structures, including stents, valves, and annuloplasty rings.
Design and application of devices that are inserted into the body or implanted to treat diseases, modulate physiological functions, or repair anatomical structures.
Minimally invasive medical devices, typically flexible tubes, inserted into body lumens to deliver substances, remove obstructions, or perform localized treatments like ablation, dialysis, or drainage.
Patents
Showing 1-10 of 123